Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Acumen Pharmaceuticals, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 2.88 · gapped below the open, never looked back. High/low 2.88 at 3:45 pm ET, 2.72 at 10:00 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Halozyme will also be the Company's exclusive supplier of clinical and commercial supplies of the active pharmaceutical ingredient for Halozyme's PH20 product.”
FILING10-K0001628280-26-021413cik 0001576885
“Although we acquired the exclusive rights to sabirnetug from Merck in 2011 following Merck's strategic decision to focus its AD development efforts on a different product candidate, we did not recommence meaningful operations until we completed our first institutional fundraising in 2018.”
FILING10-K0001628280-26-021413cik 0001576885
“In July 2025, we entered into a collaboration, option and license agreement with JCR Pharmaceuticals Co. Ltd., or JCR, to develop an Aß oligomer-targeted EBD TM therapy for AD.”
FILING10-K0001628280-26-021413cik 0001576885
“In November 2023, we entered into a loan and security agreement, or the Loan Agreement, with K2 HealthVentures LLC, or, together with its affiliates, K2HV.”
FILING10-K0001628280-26-021413cik 0001576885
“Under the terms of the Lonza License Agreement, Lonza granted the Company a worldwide non-exclusive license to use Lonza's glutamine synthetase gene expression system to manufacture and commercialize sabirnetug, or the Lonza Product.”
FILING10-K0001628280-26-021413cik 0001576885
“In connection with the filing of the 2022 Registration Statement, we also entered into a sales agreement, or the Sales Agreement, with BofA Securities, Inc., or BofA, and Stifel, Nicolaus & Company, Incorporated, or Stifel, as sales agents, pursuant to which we may issue and sell shares of our common stock for an aggregate offering price of up to $50.0 million under the ATM, which was included in the $200.0 million of securities that were registered for sale pursuant to the 2022 Registration Statement.”
FILING10-K0001628280-26-021413cik 0001576885
“On April 23, 2023, we entered into an amendment to the Sales Agreement, or as amended, the Amended Sales Agreement, to add BTIG, LLC, or BTIG, as a sales agent under the Amended Sales Agreement.”
FILING10-K0001628280-26-021413cik 0001576885
“In connection with the filing of the 2022 Registration Statement, we also entered into a sales agreement, or the Sales Agreement, with BofA Securities, Inc., or BofA, and Stifel, Nicolaus & Company, Incorporated, or Stifel, as sales agents, pursuant to which we may issue and sell shares of our common stock for an aggregate offering price of up to $50.0 million under the ATM, which was included in the $200.0 million of securities that were registered for sale pursuant to the 2022 Registration Statement.”
FILING10-K0001628280-26-021413cik 0001576885
Watchlist prices, news filtered to it, and its next report on your desk.
Acumen Pharmaceuticals, Inc. has 8 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Acumen Pharmaceuticals, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Acumen Pharmaceuticals, Inc.. Customers appear here when Acumen Pharmaceuticals, Inc. names them, or when a company names Acumen Pharmaceuticals, Inc. as a supplier in its own annual report.
ABOS (Acumen Pharmaceuticals, Inc.) has 8 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: HALO −1.49%, in healthcare.